Patents Assigned to University
  • Patent number: 8702957
    Abstract: A systems and apparatus for measuring non-electroactive materials in liquids using electrochemical detection. A first electrical activity of a electroactive material is detected in absence of a target non-electroactive material (Step 120). A second electrical activity of the electroactive material is detected in presence of the target non-electroactive material (Step 130). A difference between the first and second electrical activities is obtained, and based on the obtained difference, a concentration of the target non-electroactive material is identified (Step 140).
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: April 22, 2014
    Assignees: Arizona Board of Regents for and on behalf of Arizona State University, EMD Millipore Corporation
    Inventors: Joseph Wang, Aristotelis Dimitrakopoulos, Celine Le Ninivin, Stephane Mabic
  • Patent number: 8706434
    Abstract: The nonlinear systems measurement system includes two signal generators generating different sinusoidal frequencies. A spectrum analyzer measures all signals. A single software program synchronizes the instruments. The fetched measurements are kept in data registers in correct sequence for feeding into two curve fitting routines. The sinusoidal signals are fed to a suitable combiner for the expected frequencies and dynamic range of the UUT. The combined signal is applied to the UUT. Via a software-controlled single-pole, triple-throw RF switch, the amplitude of the UUT output and the two input signals are measured at every power step as amplitude I1 and amplitude I2. The amplitude of the output component from the UUT at f1-f2 is measured as IMD2 and the output component at 2f1-f2 is measured as IMD3. The measured I1 and IMD2 are fed to the curve-fitting routine 1, yielding r1. The measured I2 and IMD3 are fed to curve-fitting routine 2, yielding r2.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: April 22, 2014
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Muhammad Taher Abuelma'Atti, Ali Muhammad Taher Abuelma'Atti
  • Patent number: 8702390
    Abstract: A wind turbine includes a hub including at least three spaced projections and a hub cap; at least three blades each including a root plate at one end, with the root plate including a sleeve having a hole on a windward side; at least three shaft members each interconnecting the root plate and a corresponding projection; at least three sets of four abutment plates each secured to either side of the root plate or either side of the projection; U-shaped steel torsion bars each having both ends at an inclined angle of about 15 to 25 degrees fastened in the abutment plate and disposing the root plate at an angle of about 4 to 10 degrees with respect to the corresponding projection; a spring on the rotation shaft on a leeward side of the hub; and pins each installed in a hub cap and sticking into the hole.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: April 22, 2014
    Assignee: Chang Gung University
    Inventor: Ming-Tsung Sun
  • Patent number: 8705044
    Abstract: A method for detecting rotation includes providing a plurality of resonant waveguides generally adjacent to one another and optically coupled to one another. Each resonant waveguide of the plurality of resonant waveguides is configured to allow light to propagate along the resonant waveguide in a planar path. The method further includes propagating light along each path in a clockwise direction or along each path in a counterclockwise direction.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: April 22, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Matthew A. Terrel, Michel J. F. Digonnet, Shanhui Fan
  • Patent number: 8703023
    Abstract: A plasma treatment has been used to modify the surface of BNNTs. In one example, the surface of the BNNT has been modified using ammonia plasma to include amine functional groups. Amine functionalization allows BNNTs to be soluble in chloroform, which had not been possible previously. Further functionalization of amine-functionalized BNNTs with thiol-terminated organic molecules has also been demonstrated. Gold nanoparticles have been self-assembled at the surface of both amine- and thiol-functionalized boron nitride Nanotubes (BNNTs) in solution. This approach constitutes a basis for the preparation of highly functionalized BNNTs and for their utilization as nanoscale templates for assembly and integration with other nanoscale materials.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: April 22, 2014
    Assignee: The Regents of the University of California
    Inventors: Toby Sainsbury, Takashi Ikuno, Alexander K. Zettl
  • Patent number: 8701471
    Abstract: Method and system for background suppression in magneto-motive photoacoustic imaging of labeled target objects.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: April 22, 2014
    Assignee: University of Washington through its Center for Commercialiation
    Inventors: Matthew O'Donnell, Xiaohu Gao
  • Patent number: 8705875
    Abstract: A facial image may be annotated with the plurality of facial landmarks. These facial landmarks may be points or regions of the face that are indicative, either alone or in combination with other facial landmarks, of at least one demographic characteristic. Demographic characteristics include, for example, age, race, and/or gender. Based on the demographic characteristic being analyzed, one or more of these facial landmarks may be selected and arranged into an input vector. Then, the input vector may be compared to one or more of the training vectors. An outcome of this comparison may involve in the given facial image being classified into a category germane to the analyzed demographic characteristic (e.g., an age range or age, a racial category, and/or a gender).
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: April 22, 2014
    Assignee: University of North Carolina at Wilmington
    Inventor: Karl Ricanek, Jr.
  • Patent number: 8703009
    Abstract: The present invention provides for a lithium ion battery and process for creating such, comprising higher binder to carbon conductor ratios than presently used in the industry. The battery is characterized by much lower interfacial resistances at the anode and cathode as a result of initially mixing a carbon conductor with a binder, then with the active material. Further improvements in cycleability can also be realized by first mixing the carbon conductor with the active material first and then adding the binder.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: April 22, 2014
    Assignee: The Regents of the University of California
    Inventors: Gao Liu, Vincent S. Battaglia, Honghe Zheng
  • Patent number: 8703200
    Abstract: The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by administration in vivo of nanoceria particles (cerium oxide nanoparticles) to the subject. The method of the invention is useful, for example, for reducing, treating, reversing or inhibiting neovascularization in ocular tissue such as the retina, macula or cornea; in skin; in synovial tissue; in intestinal tissue; or in bone. In addition, the method of the invention is useful for reducing or inhibiting neovascularization in a neoplasm (tumors), which can be benign or malignant and, where malignant, can be a metastatic neoplasm. As such, the invention provides compositions, which contain nanoceria particles and are useful for reducing, treating, reversing or inhibiting angiogenesis in a mammalian subject.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: April 22, 2014
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: James F. McGinnis, Xiaohong Zhou, Lily L. Wong, Sudipta Seal
  • Patent number: 8702792
    Abstract: A device delivers a chemical or biological agent, the device comprises an imprint molecule (IM) to be delivered by the device; an electroactive molecularly imprinted polymer (EMIP) imprinted with the imprint molecule, the EMIP having a plurality of binding sites capable of binding the imprint; and an electric potential producing member (EPM), the EPM being capable of producing an electric potential between the EPM and the EMIP; whereby when the EMIP has a predetermined density of imprint molecule bound at the binding sites, and whereby when a sufficient potential is produced between the EPM and the EMIP, the imprint molecule is released from the binding site and thereby delivered by the device.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: April 22, 2014
    Assignee: Saint Louis University
    Inventors: Shelley D. Minteer, Jenny Ulyanova
  • Patent number: 8703744
    Abstract: Provided are methods of reducing cellular cholesterol levels using lipid particles that are capable of cellular entry. Such lipid particles may be used for treating or preventing a disease or condition that is caused by or associated with an increased cellular cholesterol level and for treating or preventing a disease or condition, that is caused by or associated with a virus, that relies on cellular cholesterol for its replication.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: April 22, 2014
    Assignee: The Chancellor, Masters and Scholars of the University of Oxford
    Inventors: Stephanie Pollock, Raymond Dwek, Nicole Zitzmann
  • Patent number: 8703801
    Abstract: New chiral and achiral oxy-substituted cyclopentyl pyridinone diketocarboxamides and their derivatives and methods for their preparations are disclosed. The compounds include tautomers, regioisomers and geometric isomers. These complex carboxamides are designed as inhibitors of HIV replication through inhibition of HIV integrase. The compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents, especially other anti-HIV compounds (including other anti-HIV integrase agents), which can be used to create combination anti-HIV cocktails. Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: April 22, 2014
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Vasu Nair, Maurice O. Okello, Abdumalik A. Nishonov, Sanjaykumar Mishra
  • Patent number: 8704575
    Abstract: Active directional couplers are provided. In accordance with certain embodiments of the invention, the subject active directional couplers are tunable. The tuning is accomplished via varactors connected to the lines of the active directional couplers. Active directional elements are provided between different lines of the subject active directional couplers to control a signal path between ports of the different lines. The active directional elements are selected from diodes, transistors, inverting amplifiers, non-inverting amplifiers, differential amplifiers, and active baluns. The lines include a phase shift element between the two ports of each line. The phase shift element is selected from a transmission line, a delay line, and a phase shifter. Advantageously, the subject lines do not have to be designed for ideal phase shifting and can be designed at near 90° or near ?/4 values.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: April 22, 2014
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Byul Hur, William Richard Eisenstadt
  • Patent number: 8703829
    Abstract: The invention provides compounds of Formula (I): R1?R2??(I) wherein R1 and R2 have any of the values or specific values defined herein, as well as compositions comprising such compounds and therapeutic methods comprising the administration of such compounds.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: April 22, 2014
    Assignee: University of Louisville Research Foundation, Inc.
    Inventors: Gerald B. Hammond, Bo Xu, Paula J. Bates
  • Patent number: 8706188
    Abstract: A method for musculoskeletal tissue segmentation used in magnetic resonance imaging (MRI) is provided. MRI image data is collected using at least two different contrast mechanisms. Voxel values from data from each contrast mechanism are used as elements of a feature vector. The feature vector is compared with classification boundaries to classify musculoskeletal tissue type of the voxel. The previous two steps are repeated for a plurality of voxels. An image is generated from the classified musculoskeletal tissue types for the plurality of voxels to provide a musculoskeletal segmentation image.
    Type: Grant
    Filed: June 4, 2008
    Date of Patent: April 22, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Seungbum Koo, Brian A. Hargreaves, Garry E. Gold
  • Patent number: 8703487
    Abstract: The invention provides compositions for making erythroid progenitor cells that comprise in vitro-activated bone marrow mesenchymal stem cells and embryoid bodies (EBs) or pluripotent stem cells, and methods for making and using them, including ameliorating (e.g., preventing or treating) anemia and/or stimulating erythropoiesis. In one embodiment, the invention provides methods of increasing propensity of committed stem cell differentiation towards the erythroid lineage.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: April 22, 2014
    Assignee: The Regents of the University of California
    Inventor: Ewa Carrier
  • Patent number: 8704133
    Abstract: A silver-containing antiseptic welding flux for stainless steel includes 0.1-0.5 wt % of silver, 30-54 wt % of silicon dioxide, 20-40 wt % of titanium dioxide, 10-20 wt % of chromium oxide, 5-20 wt % of molybdenum oxide, 5-10 wt % of molybdenum sulfide, and 5-10 wt % of halide.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: April 22, 2014
    Assignee: National Pingtung University of Science and Technology
    Inventor: Kuang-Hung Tseng
  • Patent number: 8706216
    Abstract: Methods and apparatus for a three-stage atrial cardioversion therapy that treats atrial arrhythmias within pain tolerance thresholds of a patient. An implantable therapy generator adapted to generate and selectively deliver a three-stage atrial cardioversion therapy and at least two leads, each having at least one electrode adapted to be positioned proximate the atrium of the patient. The device is programmed for delivering a three-stage atrial cardioversion therapy via both a far-field configuration and a near-field configuration of the electrodes upon detection of an atrial arrhythmia. The three-stage atrial cardioversion therapy includes a first stage for unpinning of one or more singularities associated with an atrial arrhythmia, a second stage for anti-repinning of the one or more singularities, both of which are delivered via the far-field configuration of the electrodes, and a third stage for extinguishing of the one or more singularities delivered via the near-field configuration of the electrodes.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: April 22, 2014
    Assignee: The Washington University
    Inventors: Igor Efimov, Wenwen Li, Ajit Janardhan
  • Patent number: 8704204
    Abstract: Disclosed herein are nanoscale devices comprising one or more ferroelectric nanoshells characterized as having an extreme curvature in at least one spatial dimension. Also disclosed are ferroelectric field effect transistors and metal ferroelectric metal capacitors comprising one or more ferroelectric nanoshells. Methods for controlling spontaneous ferroelectric polarization in nanoshell devices are also disclosed.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: April 22, 2014
    Assignee: Drexel University
    Inventors: Jonathan E. Spanier, Stephen S. Nonnenmann, Oren David Leaffer
  • Patent number: 8703798
    Abstract: An indoloquinoline wherein the quarternary N-5 atom is a straight C(1-5) chain, a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring; the 10 position is N—R10, O, S, S?O, CH2, or C?O, where R10 is a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring. In one embodiment the quarternary N-5 atom is —CH3 and the 10 position is N—(CH2)5-Ph.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: April 22, 2014
    Assignee: Florida A&M University
    Inventor: Seth Y. Ablordeppey